Spero Therapeutics Announces Issuance of Allowance for a U.S. Patent Covering Lead Candidate Tebipenem HBr

NEXT STORY
XBiotech Candidate True Human™ COVID-19 Therapy Found to Target Highly Infectious Emerging Strain
PREV STORY
Global Advanced Antibodies Report 2020 with Profiles of Key Companies – Advances in Antibody-based Therapies, Bispecific Antibodies (bsAbs) have Gained Momentum
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Helsinn Files Petition for Writ of Certiorari for Supreme Court Review Regarding Patent Covering Aloxi® in the US Market

Helsinn Files Petition for Writ of Certiorari for Supreme Court Review Regarding Patent Covering ...

author_avatar
NASDAQ Market News

Phase 1 Expansion Cohort Oral Presentations for Flotetuzumab, MacroGenics’ CD123 x CD3 DART® Molecule, in Relapsed/Refractory Acute Myeloid Leukemia Presented at 60th ASH Annual Meeting

Flotetuzumab demonstrated 29.4% complete response rate in evaluable primary refractory AML patientsTranslational studies suggest ...

author_avatar
NASDAQ Market News

Global Automated Microscopy Market Analysis, Trends, and Forecasts 2019-2025

author_avatar
NASDAQ Market News